ELIGARD: payments to doctors
Payments that named ELIGARD as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.4M
- Providers
- 9,286
- Transactions
- 32,783
- Average per transaction
- $42
The per-transaction average — $42 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 9,286 providers the average total is $148, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Tolmar Pharmaceuticals, Inc. | $833,783 | 60.8% |
| Tolmar, Inc. | $537,901 | 39.2% |